Nek2 Is a Novel Regulator of B Cell Development and Immunological Response
Zhimin Gu(University of Iowa), Fenghuang Zhan(Winthrop Rockefeller Foundation)
Cited by 26
Related Papers
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
|Oncotarget|2010|113
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
|Oncotarget|2014|72
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
|Journal of Clinical Investigation|2021|42